Luteal phase support using either Crinone® 8% or Utrogest®: results of a prospective, randomized study

This publication has 22 references indexed in Scilit:

• Evaluation of an optimal luteal phase support protocol in IVF
  Acta Obstetricia et Gynecologica Scandinavica, 2001
• Comparison of the pharmacokinetics of Crinone 8% administered vaginally versus Prometrium administered orally in postmenopausal women
  Fertility and Sterility, 2000
• Crinone 8% (90 mg) given once daily for progesterone replacement therapy in donor egg cycles
  Fertility and Sterility, 1999
• Use of Crinone∗ vaginal progesterone gel for luteal support in in vitro fertilization cycles
  Fertility and Sterility, 1999
• Crinone 8% vaginal progesterone gel results in lower embryonic implantation efficiency after in vitro fertilization-embryo transfer
  Fertility and Sterility, 1999
• New Hypotheses. Transvaginal progesterone: evidence for a new functional 'portal system' flowing from the vagina to the uterus
  Human Reproduction Update, 1999
• The First Uterine Pass Effect
  Annals of the New York Academy of Sciences, 1997
• Endocrinology: Progesterone alone versus progesterone combined with HCG as luteal support in GnRHa/HMG induced IVF cycles: a randomized clinical trial
  Human Reproduction, 1996
• The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone
  Human Reproduction, 1996
• Hormonal monitoring for in-vitro fertilization and related procedures
  Human Reproduction, 1988